Moderna Inc. buy The Goldman Sachs Group, Inc.
Start price
03.11.23
/
50%
€72.02
Target price
03.11.24
€215.08
Performance (%)
-30.02%
End price
04.11.24
€50.40
Summary
This prediction ended on 04.11.24 with a price of €50.40. Massive losses of -30.02% were the result for the BUY prediction by The_Goldman_Sachs_Gr. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Moderna Inc. | 171.149% | 171.149% | 524.197% |
| iShares Core DAX® | -1.059% | 5.007% | 6.596% |
| iShares Nasdaq 100 | -2.387% | 0.864% | 25.791% |
| iShares Nikkei 225® | -4.361% | 1.211% | 41.309% |
| iShares S&P 500 | -1.778% | 1.391% | 21.037% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Moderna Inc. diskutieren
Moderna, Inc. (NASDAQ: MRNA) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $269.00 to $231.00. They now have a "buy" rating on the stock.
Ratings data for MRNA provided by MarketBeat
In the thread Trading Moderna Inc.
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten